Home > Share Market > Stocks > Glaxosmithkline Pharmaceuticals Ltd > Financial Statements > GLAXO Cash Flow

GLAXO Cash Flow Statement

  • Tabular Data
  • Graph
Y/e 31 Mar ( In .Cr) Mar-2022 Mar-2021 Mar-2020 Mar-2017
Profit before tax 767 627 647 465
Depreciation (68) (79) (83) (26)
Tax paid (398) (167) (213) (174)
Working capital (45) (918) (972) (526)
Other operating items -- -- -- --
Operating cashflow 256 (536) (620) (262)
Capital expenditure 293 287 1,111 (58)
Free cash flow 549 (250) 491 (320)
Equity raised 2,735 2,958 3,548 3,584
Investments 253 (55) (10) --
Debt financing/disposal 4.91 4.61 4.32 4.72
Dividends paid -- -- -- 254
Other items -- -- -- --
Net in cash 3,542 2,657 4,033 3,523

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity